Literature DB >> 22286234

pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases.

In-Young Hwang1, Jae-Seok Roe, Ja-Hwan Seol, Hwa-Ryeon Kim, Eun-Jung Cho, Hong-Duk Youn.   

Abstract

The biological functions of Myc are to regulate cell growth,apoptosis, cell differentiation and stem-cell self-renewal. Abnormal accumulation of c-Myc is able to induce excessive proliferation of normal cells. von Hippel-Lindau protein(pVHL) is a key regulator of hypoxia-inducible factor 1α(HIF1α), thus accumulation and hyperactivation of HIF1α is the most prominent feature of VHL-mutated renal cell carcinoma. Interestingly, the Myc pathway is reported to be activated in renal cell carcinoma even though the precise molecular mechanism still remains to be established. Here, we demonstrated that pVHL locates at the c-Myc promoter region through physical interaction with Myc. Furthermore, pVHL reinforces HDAC1/2 recruitment to the Myc promoter, which leads to the auto-suppression of Myc. Therefore, one possible mechanism of Myc auto-suppression by pVHL entails removing histone acetylation. Our study identifies a novel mechanism for pVHL-mediated negative regulation of c-Myc transcription.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286234      PMCID: PMC3887712          DOI: 10.1007/s10059-012-2268-3

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  48 in total

1.  Myc-mediated transcriptional repression by recruitment of histone deacetylase.

Authors:  John F Kurland; William P Tansey
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

2.  MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.

Authors:  Sai-Wen Tang; Wen-Hsin Chang; Yih-Ching Su; Yu-Chi Chen; Yen-Han Lai; Pei-Tzu Wu; Chyong-Ing Hsu; Wei-Chou Lin; Ming-Kuen Lai; Jung-Yaw Lin
Journal:  Cancer Lett       Date:  2008-09-21       Impact factor: 8.679

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 4.  VHL and p53: tumor suppressors team up to prevent cancer.

Authors:  Gregg L Semenza
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

5.  Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.

Authors:  G M Marshall; S Gherardi; N Xu; Z Neiron; T Trahair; C J Scarlett; D K Chang; P Y Liu; K Jankowski; N Iraci; M Haber; M D Norris; J Keating; E Sekyere; G Jonquieres; F Stossi; B S Katzenellenbogen; A V Biankin; G Perini; T Liu
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

Review 6.  Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies.

Authors:  Luciano J Costa; Harry A Drabkin
Journal:  Oncologist       Date:  2007-12

7.  Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.

Authors:  Hironori Ishizaki; Hirohisa Yano; Makoto Tsuneoka; Sachiko Ogasawara; Jun Akiba; Naoyo Nishida; Sakiko Kojiro; Suguru Fukahori; Fukuko Moriya; Kei Matsuoka; Masamichi Kojiro
Journal:  Pathol Int       Date:  2007-10       Impact factor: 2.534

Review 8.  The c-myc promoter: still MysterY and challenge.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 9.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

10.  The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIM(EL).

Authors:  Y Guo; M C Schoell; R S Freeman
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

View more
  6 in total

Review 1.  The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.

Authors:  Jerry Vriend; Hassan Marzban
Journal:  Cell Mol Life Sci       Date:  2016-09-03       Impact factor: 9.261

2.  Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.

Authors:  Chunxia Zhou; Lincai Ye; Chuan Jiang; Jie Bai; Yongbin Chi; Haibo Zhang
Journal:  Tumour Biol       Date:  2015-06-19

3.  BET Protein BRDT Complexes With HDAC1, PRMT5, and TRIM28 and Functions in Transcriptional Repression During Spermatogenesis.

Authors:  Li Wang; Debra J Wolgemuth
Journal:  J Cell Biochem       Date:  2015-11-26       Impact factor: 4.429

4.  VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.

Authors:  Yao-Hui Gao; Zhao-Xia Wu; Li-Qi Xie; Cai-Xia Li; Yu-Qin Mao; Yan-Tao Duan; Bing Han; San-Feng Han; Yun Yu; Hao-Jie Lu; Peng-Yuan Yang; Tian-Rui Xu; Jing-Lin Xia; Guo-Qiang Chen; Li-Shun Wang
Journal:  Nat Commun       Date:  2017-06-15       Impact factor: 14.919

5.  c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation.

Authors:  Peiyan Zhao; Xiaodan Sun; Hui Li; Yan Liu; Yanan Cui; Lin Tian; Ying Cheng
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

6.  HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma.

Authors:  Swathi Ramakrishnan; ShengYu Ku; Eric Ciamporcero; Kiersten Marie Miles; Kris Attwood; Sreenivasulu Chintala; Li Shen; Leigh Ellis; Paula Sotomayor; Wendy Swetzig; Ray Huang; Dylan Conroy; Ashley Orillion; Gokul Das; Roberto Pili
Journal:  BMC Cancer       Date:  2016-08-09       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.